Sort
23,748 grants matching “melanoma”
Identification of Melanoma Brain Metastasis Tumor Biomarkers
$370,950Dave S B Hoon · Saint John'S Cancer Institute · R01 · FY2014 · CA
CITY OF HOPE SOUTHWEST GROUP CLINICAL TRIALS
$370,946City Of Hope/Beckman Research Institute · U10 · FY2003 · CA
Type I Interferon Responses in the Pathobiology of Anthracycline-induced Cardiotoxicity
$370,937Andrew Phillip West · Texas A&M University · R01 · FY2021 · HL
Structural Biology of GTPase Activating Proteins
$370,921R Byrd · Division Of Basic Sciences - Nci · ZIA · FY2014 · CA
USP18 in Cancer Development
$370,916Dong-Er Zhang · University Of California, San Diego · R01 · FY2023 · CA
USP18 in Cancer Development
$370,916Dong-Er Zhang · University Of California, San Diego · R01 · FY2022 · CA
Evaluation of Novel DExD/H Helicases in Innate Immune Signaling
$370,840Glen N. Barber · University Of Miami School Of Medicine · U01 · FY2010 · AI
Cell-based tumor vaccines targeting CD4+ T lymphocytes
$370,820Suzanne Ostrand-Rosenberg · University Of Maryland Baltimore County · R01 · FY2008 · CA
Abbreviated targeted therapy to improve anti-PD-1 inhibitor efficacy in melanoma
$370,800Ryan J Sullivan · Massachusetts General Hospital · R01 · FY2019 · CA
Development and Mechanistic Studies of an Engineered Human Enzyme to Abrogate Immune Suppression due to Elevated Methylthioadenosine (MTA) by MTAP null/low Tumors
$370,782Everett Stone · University Of Texas At Austin · R01 · FY2022 · CA
Development and Mechanistic Studies of an Engineered Human Enzyme to Abrogate Immune Suppression due to Elevated Methylthioadenosine (MTA) by MTAP null/low Tumors
$370,782Everett Stone · University Of Texas At Austin · R01 · FY2023 · CA
Inhibition of p53 Tumor Suppressor Function
$370,756Cynthia Masison · Division Of Basic Sciences - Nci · ZIA · FY2010 · CA
Mechanisms of PAK1 activation, signaling and tumor resistance
$370,739Channing J Der · Univ Of North Carolina Chapel Hill · R01 · FY2014 · CA
Bioengineering approaches to map mechanotransduction in the living cell
$370,714Ning Wang · University Of Illinois At Urbana-Champaign · R01 · FY2018 · GM
The Metabolic Regulation of Melanoma Metastasis
$370,699Sean J Morrison · Ut Southwestern Medical Center · U01 · FY2019 · CA
Defining the Role of the Cancer Circadian Clock in Tumor Immunity and Tumorigenesis
$370,636Chi V. Dang · Wistar Institute · R01 · FY2021 · CA
Paradoxical roles of tumor lymphangiogenesis on tumor immunity and implications for immunotherapy - Resubmission 01
$370,575Melody A Swartz · University Of Chicago · R01 · FY2018 · CA
Mechanism-rooted therapeutic strategies for immune-related toxicities induced by checkpoint inhibitors
$370,575Roza Insafetdinovna Nurieva · University Of Tx Md Anderson Can Ctr · R01 · FY2023 · CA
Mechanism-rooted therapeutic strategies for immune-related toxicities induced by checkpoint inhibitors
$370,575Roza Insafetdinovna Nurieva · University Of Tx Md Anderson Can Ctr · R01 · FY2025 · CA
Paradoxical roles of tumor lymphangiogenesis on tumor immunity and implications for immunotherapy - Resubmission 01
$370,575Melody A Swartz · University Of Chicago · R01 · FY2021 · CA
Paradoxical roles of tumor lymphangiogenesis on tumor immunity and implications for immunotherapy - Resubmission 01
$370,575Melody A Swartz · University Of Chicago · R01 · FY2020 · CA
Cis-aconitate decarboxylase (ACOD1) in PMN-MDSC and prostate cancer progression
$370,575Guocan Wang · University Of Tx Md Anderson Can Ctr · R01 · FY2025 · CA
Cis-aconitate decarboxylase (ACOD1) in PMN-MDSC and prostate cancer progression
$370,575Guocan Wang · University Of Tx Md Anderson Can Ctr · R01 · FY2023 · CA
Use of focused ultrasound to increase melanoma immunogenicity and inhibit tumor-induced T cell tolerance
$370,552Fernando Macian · Albert Einstein College Of Medicine · R01 · FY2019 · CA
Type I Interferon Responses in the Pathobiology of Anthracycline-induced Cardiotoxicity
$370,547Andrew Phillip West · Texas A&M University · R01 · FY2022 · HL